Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4588456
Max Phase: Preclinical
Molecular Formula: C21H24F3N3O4S
Molecular Weight: 471.50
Molecule Type: Unknown
Associated Items:
ID: ALA4588456
Max Phase: Preclinical
Molecular Formula: C21H24F3N3O4S
Molecular Weight: 471.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cccc(N2CCN(C(=O)C(C)(C)S(=O)(=O)c3ccc(C(F)(F)F)cn3)CC2)c1
Standard InChI: InChI=1S/C21H24F3N3O4S/c1-20(2,32(29,30)18-8-7-15(14-25-18)21(22,23)24)19(28)27-11-9-26(10-12-27)16-5-4-6-17(13-16)31-3/h4-8,13-14H,9-12H2,1-3H3
Standard InChI Key: IQQZNMYGWYNLQU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 471.50 | Molecular Weight (Monoisotopic): 471.1440 | AlogP: 3.01 | #Rotatable Bonds: 5 |
Polar Surface Area: 79.81 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.39 | CX LogP: 3.23 | CX LogD: 3.23 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.67 | Np Likeness Score: -1.53 |
1. Seleem MA, Rodrigues de Almeida N, Chhonker YS, Murry DJ, Guterres ZDR, Blocker AM, Kuwabara S, Fisher DJ, Leal ES, Martinefski MR, Bollini M, Monge ME, Ouellette SP, Conda-Sheridan M.. (2020) Synthesis and Antichlamydial Activity of Molecules Based on Dysregulators of Cylindrical Proteases., 63 (8): [PMID:32227948] [10.1021/acs.jmedchem.0c00371] |
Source(1):